Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Tidepool and Abbott’s new data integration will simplify data sharing by automating data upload to Tidepool for patients ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. Tidepool ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

general manager of Abbott's UK and Ireland diabetes care business. In clinical trials, use of the Freestyle Libre CGM range has been shown to improve blood glucose control, reducing hypoglycaemic ...

Many of us with loved ones living with diabetes want to see them thrive. We often think of ways we can ease some of their ...

A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...